RecruitingCancerImmunotherapyAdvanced Solid Tumors Cancer
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Eligible age
18+ yrs
Accepts
All genders
Locations
5 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Sponsor: Elephas
You may qualify if…
- ✓ 1. Able and willing to provide informed consent for participation
- ✓ 2. Age ≥18 years at time of consent.
- ✓ 3. Have a suspected or confirmed cancer diagnosis that is to be evaluated by means of a biopsy.
- ✓ 4. Subjects who are newly diagnosed or have suspected cancer must be treatment-naïve at the time of biopsy. All other subjects should have the biopsy performed before starting their next line of treatment.
You may not qualify if…
- ✕ 1. Have a known auto-immune disease or prior condition (prior organ transplant, chronic kidney or liver disease) that renders them ineligible for immunotherapy (IO) treatment.
- ✕ 2. Severely immunocompromised person(s). Examples include patients on immunosuppressants, HIV positive patients on antiretrovirals, post transplantation patients.
- ✕ 3. Pregnant person(s).
Where it's recruiting
Source: ClinicalTrials.gov · NCT07327489 · last updated 2026-01-08